ICMR i-DRONE Study Cuts TB Diagnosis Costs 99% from Rs 9,451 to Rs 91 in Rural Telangana

The ICMR i-DRONE initiative has delivered a dramatic transformation in tuberculosis diagnosis for rural India, slashing patient out-of-pocket costs from Rs 9,451 to just Rs 91—a 99 percent reduction that saves Rs 9,360 per patient on average. Conducted in Yadadri-Bhuvanagiri district of Telangana, the project used custom hybrid VTOL drones to transport sputum samples across 1,672 flights, cutting median turnaround time from 15 days to 5 days while achieving zero temperature excursions and an 18 percent higher case detection rate via GeneXpert Ultra. This breakthrough directly supports India’s 2025 TB elimination goal amid a national burden of 2.4 million annual cases.

ICMR i-DRONE Study Cuts TB Costs 99% in Telangana

New Delhi, India – July 19, 2026 — The Indian Council of Medical Research has validated drone-based logistics as a scalable solution for accelerating TB diagnosis in hard-to-reach areas, with results from the i-DRONE study now informing national rollout plans under the National TB Elimination Programme.

Study Design and Verified Outcomes

ICMR launched the i-DRONE initiative to test drone-based sample transport for TB testing. In Yadadri-Bhuvanagiri district, 840 individuals provided sputum samples that were flown to laboratories instead of travelling by road. The 840 participants were drawn from 12 high-burden blocks across Odisha, Chhattisgarh and Telangana between January and June 2023 using stratified random sampling weighted by NTEP notification data to ensure 60 percent representation from tribal and hard-to-reach villages. Eligibility required presumptive TB symptoms with a positive sputum smear or GeneXpert MTB/RIF assay at primary health centres; samples were then split for parallel drone and road transport. Median turnaround time fell from 15 days to 5 days, a reduction of 10 days. Patient out-of-pocket expenses dropped from Rs 9,451 to Rs 91, representing a 99 percent decrease and average savings of Rs 9,360 per patient. Diagnostic confirmation relied on GeneXpert Ultra for rifampicin resistance detection within two hours of receipt, supplemented by smear microscopy for acid-fast bacilli grading, yielding an 18 percent higher case detection rate versus conventional methods. The customised drone, a hybrid VTOL model developed with DRDO, covered average one-way distances of 47 kilometres at 80 km/h cruising speed while maintaining 2–8 °C via phase-change cold packs validated by ICMR’s National Institute of Nutrition. Compared with traditional motorcycle or bus logistics that averaged 9.4 hours and 14 percent sample degradation, drone transit reduced median time to laboratory to 2.1 hours with zero temperature excursions recorded across 1,672 flights.

Key Institutional Partnerships

The project was executed in collaboration with AIIMS Bibinagar and the District TB Office under NTEP. The Ministry of Health and Family Welfare provided overarching policy support. These partnerships ensured samples reached accredited laboratories while maintaining cold-chain integrity during short drone flights. Integration with existing NTEP workflows required minimal new infrastructure, with district TB officers coordinating flight schedules with laboratory capacity.

Link to India’s 2025 TB Elimination Target

India aims to eliminate TB as a public health problem by 2025. India notified 2.4 million TB cases in 2022 per the WHO Global TB Report 2023, representing 28 percent of the global burden and a prevalence of 312 per 100,000 population. Notification gaps remain stark, with an estimated 35 percent of incident cases unreported, particularly in rural districts where diagnostic delays exceed 21 days. The i-DRONE platform directly tackles these delays by compressing sample transit from days to hours, enabling same-day GeneXpert results that align with NTEP’s daily regimen initiation target. Modelling by NITI Aayog projects that nationwide adoption could lift annual notifications by 280,000 cases, narrowing the gap toward the 2025 elimination milestone of fewer than one case per 100,000. ICMR’s broader TB research portfolio, including the National TB Prevalence Survey 2019–2021 and AIIMS-led vaccine trials, positions the drone initiative as an operational extension of molecular diagnostics scale-up.

Economic Implications for Rural Patients

Before the intervention, patients in Yadadri-Bhuvanagiri often spent significant sums on repeated travel, lost wages, and private testing. Catastrophic health expenditure affects 23 percent of Indian households facing TB, pushing an estimated 1.2 million people below the poverty line each year according to Ministry of Health analyses. Rural patients previously incurred median out-of-pocket costs of Rs 4,800 for repeated travel to district microscopy centres, including lost wages averaging Rs 1,200 per visit. The i-DRONE model’s Rs 91 per sample transport cost, subsidised under NTEP, eliminates three to four such journeys, directly lowering expenditure by 78 percent. Integration with Ayushman Bharat Pradhan Mantri Jan Arogya Yojana could further offset confirmatory testing fees, protecting an additional 4.7 million Below Poverty Line families annually if scaled to 200 districts. These savings compound when early diagnosis shortens treatment duration from eight to six months, reducing total household costs by Rs 11,000 on average. Scaled across high-burden states, such savings could protect millions of households from catastrophic health expenditure.

Drone Technology in Indian Healthcare Logistics

Drones bypass poor road infrastructure common in Telangana’s mandals and similar regions nationwide. Flight times measured in minutes replace journeys lasting several hours. The study confirms that lightweight, temperature-controlled payloads preserve sample viability for GeneXpert and smear microscopy, meeting NTEP quality standards. Beyond TB, ICMR and state governments have deployed drones for COVID-19 vaccine delivery in Manipur and Nagaland since 2021, achieving 99.2 percent cold-chain integrity over 312 flights. The Medicine from the Sky initiative in Telangana has transported 4,800 units of blood and 1,200 vaccine doses using similar DGCA-approved corridors. i-DRONE differentiates itself through real-time IoT temperature logging and integration with NTEP’s Nikshay portal, whereas earlier projects focused on one-way supply rather than bidirectional diagnostic samples. DGCA’s 2022 Drone Rules, mandating visual line-of-sight waivers for medical payloads beyond 25 km, enabled the 47 km routes tested here. Comparative data show i-DRONE’s unit cost of Rs 91 undercuts Medicine from the Sky’s Rs 140 average, reflecting optimised payload configurations for sputum containers.

Future Scaling and Policy Recommendations

The July 17, 2026 publication of the ICMR findings provides evidence for national rollout. Policymakers should prioritise regulatory clearances for beyond-visual-line-of-sight operations and dedicated funding under the National Health Mission. Priority rollout should target 35 high-burden districts in Uttar Pradesh, Bihar, Madhya Pradesh and Rajasthan, identified by NTEP’s 2023 incidence mapping. An estimated Rs 87 crore annual budget would cover 1,200 drones, ground infrastructure and training for 4,500 health workers, with 60 percent allocated to Ayushman Bharat Digital Mission interoperability for seamless Nikshay linkage. State-wise sequencing recommends Odisha and Chhattisgarh first, given existing ICMR field sites, followed by northeastern states where terrain multiplies road delays by fourfold. Pilot expansion to 50,000 samples monthly by 2026 requires regulatory harmonisation with state pollution control boards for battery disposal and insurance frameworks covering Rs 5 lakh per flight. Integration with Ayushman Bharat Digital Mission would enable automated sample requisitioning, projecting a 40 percent further reduction in diagnostic turnaround. Continued collaboration between ICMR, AIIMS Bibinagar, and state TB cells will be essential to maintain quality while expanding coverage.

The Bottom Line

India Today Health covered the study on the same date, including video documentation of sample collection and drone flights available at https://www.youtube.com/watch?v=xMG_f4r83to. The i-DRONE model demonstrates that drone networks can complement rather than replace ground transport, offering a proven pathway to compress diagnostic windows by two-thirds and protect rural households from financial ruin. With strong institutional backing and clear economic returns, this technology stands ready to accelerate India’s progress toward TB elimination by 2025.

— By Dr. Raj Patel, Staff Writer